Subscribe to RSS - Fisher & Paykel Healthcare

Fisher & Paykel Healthcare

In brief: OIG report, call for proposals, new videocast

 - 
08/28/2020

WASHINGTON – Medicare contractors were inconsistent in how they reviewed overpayments during the appeals process, says the Office of Inspector General in a new report.

F&P launches mask setup app

 - 
08/28/2020

IRVINE, Calif. – Fisher & Paykel Healthcare has launched the F&P myMask, an app to guide obstructive sleep apnea patients who are new to CPAP therapy through the mask setup process.

F&P plans for 3rd manufacturing facility in Mexico

 - 
08/21/2020

IRVINE, Calif. – Fisher & Paykel Healthcare has started planning for its third manufacturing facility in Mexico.

F&P’s Evora: A mask fit for the times

 - 
08/03/2020

IRVINE, Calif. – Launching a product in the middle of a global pandemic is a challenge, but Fisher & Paykel Healthcare believes its new mask has a number of features that makes it an easier sell for HME providers and users.

F&P’s nasal high flow therapy in spotlight

 - 
07/02/2020

IRVINE, Calif. – Fisher & Paykel Healthcare’s Optiflow nasal high flow therapy has gained traction as a preferred treatment for COVID-19, as hospitals move away from an “early intubation and mechanical ventilation” mentality, company officials say.

F&P’s homecare group sees 9% increase in revenues

 - 
06/30/2020

IRVINE, Calif. – Fisher & Paykel Healthcare reported operating revenue of $1.26 billion for its fiscal year ended March 31, 2020, an 18% increase compared to 2019 or a 14% increase in constant currency.

F&P upgrades guidance

 - 
08/29/2019

IRVINE, Calif. – Fisher & Paykel Healthcare has upgraded its guidance for the financial year ending March 31, 2020, to full operating revenue of about $1.17 billion and net profit after tax of about $245 million to $255 million.

ResMed, F&P put patent disputes behind them

 - 
02/20/2019

SAN DIEGO and AUCKLAND, N.Z. – ResMed and Fisher & Paykel Healthcare have agreed to settle all outstanding patent infringement disputes between the two companies.

ResMed wins in German court

 - 
10/23/2018

SAN DIEGO – A trial court ruling from the Munich District Court says the headgear used on two CPAP masks from Fisher & Paykel Healthcare—the Simplus full-face and Eson nasal—infringes a ResMed patent in Germany.

New leadership: Fisher & Paykel, BioScrip

 - 
10/23/2018

Fisher & Paykel Healthcare has appointed Lyndal York CFO. She will join the company in March 2019 and will report to CEO Lewis Gradon.

Pages